Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

SIOG 2017 /
Patient adherence to oral therapies

9th - 11th Nov 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 15.11.17
Views: 1211

Dr Ginah Nightingale - Thomas Jefferson University, Philadelphia, USA

Dr Ginah Nightingale talks to ecancer at SIOG 2017 in Warsaw.

She discusses the adherence of oral therapies by patients.

Dr Nightingale suggests that by observing their commitment to other therapies, they can judge how likely they will be to take their chemotherapies. 

One way of doing this would be to have more face-to-face check ups. 

This service has been kindly supported by an unrestricted grant from Janssen Oncology.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation